The CDC recommends that immunocompromised people and those age 65 and older should get a second dose of the 2024-2025 COVID ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Results from a randomized control trial published Nov. 6 in JAMA Network Open show that participants who received mRNA ...

If you missed the early fall push for flu and COVID-19 vaccines, it's not too late.Health officials say it's important to get ...

the Food and Drug Administration authorized and approved updated COVID-19 vaccines that target JN.1-lineage omicron variants ...

Researchers investigate how public trust in the science of COVID-19 vaccines has changed in the United States.

The rapid development of COVID-19 vaccines has been instrumental in controlling the spread and severity of severe acute ...

Novavax is a protein subunit vaccine, meaning it contains pieces of the actual coronavirus’s spike protein, and thus teaches the immune system how to recognize SARS-CoV-2. The vaccine also ...

Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed ...

The updated COVID-19 vaccines will be available in the Eastern Ontario Health Unit (EOHU) region starting the week of8.

The CDC recommends that immunocompromised people age 65 and older should get a second dose of the 2024-2025 COVID vaccine.

The authors said the main outcomes of the study were reactogenicity, including fever, chills, muscle aches, and/or joint pain ...